Stem cell therapy has become an increasingly discussed area of regenerative medicine, particularly for conditions involving chronic inflammation, joint degeneration, and tissue injury. However, terms such as regeneration and repair can sometimes create expectations that go beyond what current medical evidence supports.
Umbilical Cord Derived Mesenchymal Stem Cells, or UC-MSCs, are being investigated for their ability to regulate inflammation, influence immune activity, and support the biological environment involved in tissue repair. They are not designed to rebuild every damaged structure or correct mechanical abnormalities such as severe joint deformity, complete ligament rupture, or significant nerve compression.
For patients considering treatment, understanding both the potential benefits and the limitations of stem cell therapy is essential. Realistic expectations depend on the condition being treated, the severity of disease, the characteristics of the patient, the quality of the cellular product, and the overall treatment plan.
How Does UC-MSC Therapy Work?
UC-MSCs appear to exert much of their biological activity through signaling rather than by permanently replacing damaged tissue.
Research into mesenchymal stromal cells has shifted considerably over the past decade. Earlier theories focused heavily on the possibility that MSCs could migrate to damaged tissue, differentiate into new cells, and directly replace what had been lost. Current understanding places much greater emphasis on paracrine signaling and immunomodulation.
Through paracrine signaling, MSCs release cytokines, growth factors, extracellular vesicles, and other biologically active molecules. These signals can interact with immune cells and surrounding tissues, potentially helping regulate inflammation and support local repair processes.
This distinction is important. Supporting the biological environment around injured tissue is not the same as creating a completely new joint, ligament, nerve, or organ.
UC-MSCs also do not generally remain permanently within the body. Their therapeutic effects are considered biological and time dependent, and individual responses can vary substantially.
What Are the Potential Benefits of Stem Cell Therapy?
The potential benefits of MSC therapy depend strongly on the medical condition being treated.
Among the most extensively studied applications is knee osteoarthritis. Multiple controlled studies and systematic reviews have reported that MSC treatment may improve pain and physical function in selected patients with knee osteoarthritis. At the same time, researchers continue to report considerable differences between studies in cell source, dose, preparation methods, patient characteristics, and outcome measures.
This means the evidence should be interpreted carefully. Improvement in symptoms does not necessarily mean that damaged cartilage has been completely restored.
For orthopedic patients, realistic treatment objectives may include reducing pain, improving mobility, increasing activity tolerance, and supporting a more favorable joint environment.
For neurological and other systemic conditions, MSC research is also expanding, but the strength of clinical evidence varies substantially according to the disease. Many of these applications remain investigational, and promising biological mechanisms should not be interpreted as proof of predictable clinical benefit.
What Are the Main Limitations of Stem Cell Therapy?
One of the most important limitations is that biological treatment cannot correct every structural problem.
For example, stem cell therapy cannot physically realign a severely deformed knee. It cannot remove a loose body from a joint. It cannot mechanically reconnect a completely ruptured ligament, nor can it directly create additional space around a nerve when severe structural narrowing is causing compression.
These conditions involve a mechanical component that may require another treatment strategy.
This is why appropriate diagnosis should come before the decision to use regenerative medicine. The presence of pain or degeneration alone does not determine whether stem cell therapy is suitable.
Another limitation is variability. Even patients with the same diagnosis may respond differently because their underlying disease severity, anatomy, general health, activity level, and rehabilitation needs may differ.
Stem cell therapy should therefore not be presented as a predictable formula or as a treatment that guarantees improvement.
Can Stem Cells Regrow Cartilage?
MSC therapy is being investigated for its potential effects on cartilage, but predictable regeneration of substantial amounts of damaged cartilage has not been established.
Some laboratory and clinical research suggests that MSCs may influence cartilage-related biological pathways and the joint environment. However, systematic reviews of clinical studies continue to find greater consistency in outcomes related to pain and physical function than in evidence of structural cartilage restoration. This distinction is particularly important for patients with advanced osteoarthritis.
A patient may experience meaningful improvement in pain or mobility without developing completely new cartilage on imaging. Conversely, biological treatment cannot be expected to reverse severe joint deformity or advanced structural deterioration in every patient.
Claims that stem cells will simply “regrow the cartilage” therefore oversimplify the current evidence.
Why Do Stem Cell Therapy Results Vary Between Patients?
Treatment outcomes depend on more than the cells themselves.
Disease severity is particularly important. A patient with moderate cartilage degeneration and relatively preserved joint mechanics may have a very different clinical situation from someone with severe joint-space loss, marked malalignment, significant muscle weakness, or multiple associated injuries.
Other factors may include age, body weight, metabolic health, previous surgery, activity level, duration of symptoms, muscle strength, rehabilitation, and the presence of additional structural problems.
The cellular product introduces another layer of variability. Cell source, manufacturing methods, dose, viability, passage, storage conditions, administration route, and treatment timing may differ between clinical protocols.
This is one reason why results from one patient or one study cannot automatically be applied to every person considering treatment.
Can Stem Cell Therapy Replace Surgery?
Stem cell therapy may be considered as part of conservative treatment in selected patients, but it cannot universally replace surgery.
The appropriate treatment depends on the primary cause of the patient’s symptoms.
If pain is associated with inflammation and degenerative changes without a major mechanical problem, regenerative treatment may be considered as one option. If symptoms are primarily caused by severe instability, significant deformity, mechanical obstruction, or nerve compression, correcting the structure itself may be more important.
In these situations, surgery may remain the more appropriate treatment.
Stem cell therapy can also sometimes be considered within a broader recovery strategy rather than as an alternative to every other medical intervention.
Why Does Rehabilitation Still Matter After Stem Cell Therapy?
Regenerative medicine and rehabilitation address different components of recovery.
UC-MSC therapy primarily targets biological processes, while rehabilitation addresses muscle strength, mobility, joint mechanics, balance, and functional capacity.
This is especially relevant in osteoarthritis. Exercise remains one of the strongest recommendations in established clinical guidelines for knee and hip osteoarthritis. Weight management is also strongly recommended when excess body weight is contributing to joint loading.
For a knee patient, reducing inflammation without improving weak quadriceps or poor movement mechanics may leave important contributors to the problem unchanged.
A useful way to understand this relationship is that regenerative treatment may help support the biological environment, while rehabilitation works on the mechanical and functional environment. Neither necessarily replaces the other.
Who May Be an Appropriate Candidate for Stem Cell Therapy?
Suitability should be determined individually rather than by diagnosis alone.
A proper assessment may consider the patient’s symptoms, medical history, imaging findings, severity of disease, previous treatments, overall health, functional goals, and available alternatives.
For orthopedic conditions, MRI or X-ray findings may help identify structural abnormalities that regenerative treatment cannot correct. Neurological patients may require a different assessment focused on diagnosis, chronicity, functional impairment, and rehabilitation potential.
A medically responsible approach should also allow for the conclusion that stem cell therapy is not appropriate.
Depending on the individual case, physiotherapy, medication, PRP, surgery, lifestyle intervention, or continued observation may be more suitable.
What Should Patients Realistically Expect From Stem Cell Therapy?
The most useful expectations are usually based on meaningful changes in symptoms and function rather than promises of complete regeneration.
For a patient with knee osteoarthritis, this might mean less pain while walking, easier stair climbing, improved mobility, or greater ability to exercise and participate in rehabilitation.
Response may also be gradual. Biological therapies should not necessarily be judged by what happens within the first few days after administration.
Some patients may experience meaningful improvement, some may notice more modest changes, and others may experience little or no clinically significant benefit.
That variability is part of current regenerative medicine and should be discussed before treatment.
Stem cells are not magic. Their potential value lies in using their biological properties appropriately, in the right patient, for a condition that those biological mechanisms may reasonably help.
Frequently Asked Questions
- Does stem cell therapy work for everyone?
No. Outcomes vary according to the condition, disease severity, individual health factors, treatment protocol, and characteristics of the cellular product. No responsible treatment should guarantee improvement.
- Can stem cells completely regrow damaged cartilage?
Current evidence does not support guaranteeing complete cartilage restoration. Clinical studies have shown more consistent evidence for improvements in pain and function than for predictable structural cartilage regeneration.
- Can stem cell therapy prevent knee replacement?
Some patients may consider regenerative treatment as part of conservative management, but it cannot replace joint replacement in every case. Severe deformity, extensive structural damage, instability, and persistent symptoms may still require surgery.
- Why do I still need physiotherapy after stem cell treatment?
Stem cell therapy and rehabilitation have different roles. Cellular treatment may influence the biological environment, while physiotherapy helps restore strength, movement, stability, and function.
- How long does it take to know whether stem cell therapy has helped?
There is no single timeframe that applies to every patient. Clinical response may develop gradually and depends on the condition, route of administration, disease severity, and individual biology.
About EDNA Wellness
EDNA Wellness is a surgeon-led regenerative medicine center in Bangkok, specializing in orthopedic and neurological conditions using Umbilical Cord Derived Mesenchymal Stem Cells (UC-MSCs).
All cases are reviewed by orthopedic surgeons and neurosurgeons, with a focus on clinical indication, patient safety, and realistic treatment expectations. Stem cell therapy is recommended selectively, and alternative treatments are considered when more appropriate.
For more information or to book a consultation:
LINE: @ednawellness
WhatsApp: +66 (0) 64 505 5599
Website: www.ednawellness.com
References
- Pittenger MF, Discher DE, Péault BM, et al. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regenerative Medicine. 2019. https://www.nature.com/articles/s41536-019-0083-6?
- Tabet CG, Pacheco RL, Martimbianco ALC, et al. Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: Systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Translation. 2024. https://pubmed.ncbi.nlm.nih.gov/39360004/
- Sadeghirad B, Rehman Y, Khosravirad A, et al. Mesenchymal stem cells for chronic knee pain secondary to osteoarthritis: A systematic review and meta-analysis of randomized trials. Osteoarthritis and Cartilage. 2024. https://pubmed.ncbi.nlm.nih.gov/38777213/
- Tian X, Qu Z, Cao Y, Zhang B. Relative efficacy and safety of mesenchymal stem cells for osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Endocrinology. 2024. https://pubmed.ncbi.nlm.nih.gov/38915896/
- Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis & Rheumatology. 2020. https://pubmed.ncbi.nlm.nih.gov/31908163/